Erasca, Inc. (ERAS) Income Statement
ERAS 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsERAS revenue and net income
ERAS growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
ERAS quarterly EPS vs estimates
Erasca beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 11, 2026 (estimate $-0.14).
ERAS income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $3.1M | $3.8M | $3.7M | $2.6M | $829,000 | $540,000 | $310,000 |
| Gross profit | −$3.1M | −$3.8M | −$3.7M | −$2.6M | −$829,000 | −$540,000 | −$310,000 |
| Research & development | $92.9M | $115.4M | $103.8M | $112.5M | $73.9M | $101.3M | $9.6M |
| Sales, general & admin | $38.6M | $41.7M | $37.7M | $33.0M | $22.6M | $8.0M | $3.7M |
| Total operating expenses | $128.3M | $179.6M | $137.8M | $244.8M | $124.1M | $109.3M | $13.3M |
| Operating income | −$131.4M | −$179.6M | −$141.5M | −$247.4M | −$124.9M | −$109.3M | −$13.3M |
| Interest income | $16.6M | $20.1M | $15.4M | $4.9M | $190,000 | $336,000 | $1.3M |
| Interest expense | — | — | — | $201.4M | $55.9M | $336,000 | $0 |
| Income before taxes | −$124.5M | −$161.7M | −$125.0M | −$242.8M | −$122.8M | −$101.7M | −$12.0M |
| Income taxes | — | — | — | −$4.6M | $27.3M | $71.4M | −$1.3M |
| Net income | −$124.5M | −$161.7M | −$125.0M | −$242.8M | −$122.8M | −$101.7M | −$12.0M |
| EBITDA | −$121.4M | −$153.3M | −$121.3M | −$240.2M | −$121.9M | −$37.0M | −$13.0M |
| EPS (diluted) | −$0.44 | −$0.74 | −$0.83 | −$1.96 | −$2.67 | −$0.68 | −$0.96 |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $4.2M | $0 | $0 | $0 | $5.6M | $0 |
| Cost of revenue | — | $723,000 | $743,000 | — | $787,000 | $822,000 | $832,000 | $842,000 | $1.1M | $998,000 | $942,000 | $941,000 |
| Gross profit | — | −$723,000 | −$743,000 | — | −$787,000 | −$822,000 | −$832,000 | −$842,000 | −$1.1M | −$998,000 | −$942,000 | −$941,000 |
| Research & development | $35.9M | $27.3M | $23.2M | $22.5M | $21.2M | $26.0M | $26.1M | $27.6M | $33.0M | $28.6M | $24.8M | $25.2M |
| Sales, general & admin | $11.7M | $10.6M | $9.4M | $10.1M | $9.5M | $9.7M | $9.6M | $9.6M | $13.3M | $10.3M | $9.1M | $9.4M |
| Total operating expenses | $47.6M | $37.2M | $31.9M | $34.5M | $38.1M | $35.6M | $34.9M | $37.2M | $67.8M | $37.9M | $32.9M | $34.7M |
| Operating income | −$47.6M | −$37.9M | −$32.6M | −$34.5M | −$38.1M | −$35.6M | −$35.7M | −$37.2M | −$67.8M | −$38.9M | −$33.9M | −$34.7M |
| Interest income | $3.6M | $4.4M | $3.6M | $4.0M | $4.3M | $4.7M | $5.3M | $5.9M | $5.0M | $3.9M | $4.2M | $4.3M |
| Interest expense | — | — | — | — | — | — | — | — | — | — | $3.8M | — |
| Income before taxes | −$44.1M | −$183.4M | −$29.1M | −$30.6M | −$33.9M | −$31.0M | −$32.2M | −$31.2M | −$63.2M | −$35.0M | −$29.7M | −$30.4M |
| Income taxes | — | — | — | — | — | — | −$954,724 | — | — | $954,724 | $13.4M | −$5.3M |
| Net income | −$44.1M | −$183.4M | −$29.1M | −$30.6M | −$33.9M | −$31.0M | −$32.2M | −$31.2M | −$63.2M | −$35.0M | −$29.7M | −$30.4M |
| EBITDA | −$43.4M | −$182.7M | −$28.3M | −$29.9M | −$29.8M | −$30.1M | −$31.4M | −$30.4M | −$44.1M | −$34.0M | −$28.8M | −$29.4M |
| EPS (diluted) | −$0.14 | −$0.60 | −$0.10 | −$0.11 | −$0.12 | −$0.11 | −$0.11 | −$0.11 | −$0.29 | −$0.23 | −$0.20 | −$0.20 |
| Gross margin | — | — | — | — | — | — | −19.8% | — | — | — | −16.9% | — |
| Operating margin | — | — | — | — | — | — | −851.1% | — | — | — | −607.0% | — |
| Net margin | — | — | — | — | — | — | −768.2% | — | — | — | −532.3% | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in ERAS's financial statements (latest annual report filed March 12, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
ERAS financial results
Erasca reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of $124.5 million. Diluted earnings per share came to −$0.44.
See the ERAS stock overview for the latest quote and news, or the ERAS chart for price history and technical indicators.
ERAS income statement FAQ
Does Erasca have revenue?
Erasca reported no revenue for fiscal year 2025, which ended on December 31, 2025.
Is Erasca profitable?
No. Erasca reported a net loss of $124.5 million in fiscal 2025.
How much does Erasca spend on research and development?
Erasca spent $92.9 million on research and development in fiscal 2025.
What are Erasca's earnings per share?
Erasca earned $-0.44 per diluted share in fiscal 2025, compared with $-0.74 a year earlier.
When will Erasca report its next earnings?
Erasca is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes.
When does Erasca's fiscal year end?
Erasca's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 12, 2026.